Fecal transplant turns cancer immunotherapy non-responders into responders
Dutch latest to limit AstraZeneca vaccine to under-65s
4 February 2021Major medical groups urge Americans to get COVID vaccine
4 February 2021Fecal transplant turns cancer immunotherapy non-responders into responders
Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy—which has a failure rate of 40% for this type of cancer—into patients who do.
